Mather Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.11K Buy
362
+214
+145% +$5.17K ﹤0.01% 1707
2026
Q2
$3.64K Sell
148
-16
-10% -$370 ﹤0.01% 1672
2026
Q1
$3.92K Buy
+164
New +$4.01K ﹤0.01% 1615
2025
Q4
– Sell
-112
Closed -$2.26K – 931
2025
Q3
$2.26K Buy
+112
New +$1.88K ﹤0.01% 1522
2025
Q2
– Sell
-32
Closed -$336 – 930
2025
Q1
$336 Buy
+32
New +$362 ﹤0.01% 1709
2024
Q3
– Sell
-156
Closed -$2.54K – 1845
2024
Q2
$2.54K Buy
+156
New +$2.49K ﹤0.01% 1821

Other funds holding ELAN

Mather Group's ELAN Position: Q3 2026 in Review

Mather Group increased its Elanco Animal Health (ELAN) stake by 145% in Q3 2026, buying an estimated $5.17K and bringing the position to 362 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

Mather Group first reported a position in ELAN in Q2 2024 and has held it in 6 quarters since. 262 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • Mather Group held 362 shares of Elanco Animal Health worth $8.11K as of Q3 2026.
  • Mather Group bought 214 Elanco Animal Health shares in Q3 2026, an estimated $5.17K.
  • Elanco Animal Health made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1707 holding.
  • Mather Group first reported a position in Elanco Animal Health in Q2 2024 and has held it in 6 quarters since.
  • 262 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.